Boehringer Ingelheim Prescription Medicines: effective primary and specialist care worldwide
These medicinal products require prescription either by primary care physicians or by specialists or form an integral part of hospital treatment. Branded Prescription Medicines, which represents the bulk of our Human Pharmaceuticals business, accounts for 74 % of our total net sales and generated in 2007 EUR 8,100 million.
Indication areas
Boehringer Ingelheim's product portfolio covers the following main indications:
- Acute Coronary Disease
- Arthritis
- Benign Prostatic Hyperplasia
- Chronic Obstructive Pulmonary Disease (COPD)
- HIV/AIDS
- Hypertension
- Major Depressive Disorder (MDD)
- Parkinson Disease
- Restless Legs Syndrome
- Stroke
- Thromboembolic Diseases
Other Indications
Just to mention a few of our other indications:
- generalised anxiety disorder
- diabetic peripheral neuropathic pain (DPNP)
- acute ischaemic stroke
